“…On the contrary, we maintained the same between-the-groups comparison across all included studies and could not find any significant difference in Stent Thrombosis rate among. Nevertheless, it should be remembered that the risk for Stent Thrombosis has a large interindividual variability, being influenced both by patient-related factors such as diabetes, chronic kidney disease and prior stent thrombosis, and by lesion-specific factors, such as location, number and length of treated lesions, lesion anatomy and procedural factors, like stent under-expansion, geographic miss and iatrogenic dissection [ 14 ]. Stent thrombosis rate was highest among patients receiving DAPT for only 1 month in the PIONEER AF-PCI.…”